The life-sciences company expects its capsules and health business to return to growth in 2025, after sales and earnings fell last year on slower demand.
Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback